A citation-based method for searching scientific literature

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
Times Cited: 143



Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Xuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Maartje J Hooning, Rodica Mandel, Filippo Santoro, Gek Kwan-Lim, Thomas H Helbich, Madeleine M A Tilanus-Linthorst, Edwin R van den Heuvel, Nehmat Houssami. Br J Cancer 2016
Times Cited: 48




List of shared articles



Times cited

Prevalent versus incident breast cancers: benefits of clinical and radiological monitoring in women with pathogenic BRCA1/2 variants.
Claire Saule, Solveig Menu-Hespel, Matthieu Carton, Caroline Malhaire, Pascal Cherel, Fabien Reyal, Marine Le Mentec, Eugénie Guillot, Anne Donnadieu, Nasrine Callet,[...]. Eur J Hum Genet 2022
0

Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.
Natsuko Onishi, Masako Kataoka. Breast Cancer 2021
2

[High-risk screening using magnetic resonance imaging].
Ulrich Bick. Radiologe 2021
0

The Distinct Performances of Ultrasound, Mammograms, and MRI in Detecting Breast Cancer in Patients With Germline Pathogenic Variants in Cancer Predisposition Genes.
Jiaqi Liu, Xin Wang, Lin Dong, Xin Huang, Hengqiang Zhao, Jiaxin Li, Shengkai Huang, Pei Yuan, Wenyan Wang, Jie Wang,[...]. Front Oncol 2021
0

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families.
Marion Imbert-Bouteille, Carole Corsini, Marie-Christine Picot, Lucas Mizrahy, Sandrine Akouete, Helena Huguet, Frédéric Thomas, David Geneviève, Patrice Taourel, Marc Ychou,[...]. Genes (Basel) 2021
0

Overview in Breast Cancer Screening in Lebanon.
Eman Sbaity, Rachelle Bejjany, Malek Kreidieh, Sally Temraz, Ali Shamseddine. Cancer Control 2021
0

Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Anna M Chiarelli, Kristina M Blackmore, Derek Muradali, Susan J Done, Vicky Majpruz, Ashini Weerasinghe, Lucia Mirea, Andrea Eisen, Linda Rabeneck, Ellen Warner. J Natl Cancer Inst 2020
23

Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
Francesco Sardanelli, Andrea Cozzi, Rubina Manuela Trimboli, Simone Schiaffino. AJR Am J Roentgenol 2020
13

Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil.
Maria Isabel Achatz, Maira Caleffi, Rodrigo Guindalini, Renato Moretti Marques, Angelica Nogueira-Rodrigues, Patricia Ashton-Prolla. JCO Glob Oncol 2020
9

Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study.
Francesco Sardanelli, Rubina M Trimboli, Nehmat Houssami, Fiona J Gilbert, Thomas H Helbich, Marina Alvarez Benito, Corinne Balleyguier, Massimo Bazzocchi, Peter Bult, Massimo Calabrese,[...]. Eur Radiol 2020
9

Screening in patients with increased risk of breast cancer (part 2). Where are we now? Actual MRI screening controversies.
S Alonso Roca, A B Delgado Laguna, J Arantzeta Lexarreta, B Cajal Campo, A López Ruiz. Radiologia (Engl Ed) 2020
1

Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?
Kristen D Whitaker, Deepa Sheth, Olufunmilayo I Olopade. Breast Cancer Res Treat 2020
3

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.
Rodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, Kristen Whitaker, Toshio F Yoshimatsu, Tom Walsh, David Schacht, Kirti Kulkarni, Deepa Sheth, Marion S Verp,[...]. Clin Cancer Res 2019
27

Contrast-enhanced MRI for breast cancer screening.
Ritse M Mann, Christiane K Kuhl, Linda Moy. J Magn Reson Imaging 2019
69

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
Ulrich Bick, Christoph Engel, Barbara Krug, Walter Heindel, Eva M Fallenberg, Kerstin Rhiem, David Maintz, Michael Golatta, Dorothee Speiser, Dorothea Rjosk-Dendorfer,[...]. Breast Cancer Res Treat 2019
42

BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
Mai Elezaby, Brittany Lees, Katherine E Maturen, Lisa Barroilhet, Kari B Wisinski, Sarina Schrager, Lee G Wilke, Elizabeth Sadowski. Radiology 2019
17

Assessment of breast self- examination practice and associated factors among female workers in Debre Tabor Town public health facilities, North West Ethiopia, 2018: Cross- sectional study.
Asrat Hailu Dagne, Alemu Degu Ayele, Ephrem Mengesha Assefa. PLoS One 2019
12

Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment.
Georg J Wengert, Thomas H Helbich, Doris Leithner, Elizabeth A Morris, Pascal A T Baltzer, Katja Pinker. Curr Breast Cancer Rep 2019
0

Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Suzan Vreemann, Albert Gubern-Mérida, Margrethe S Schlooz-Vries, Peter Bult, Carla H van Gils, Nicoline Hoogerbrugge, Nico Karssemeijer, Ritse M Mann. Radiology 2018
27

Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.
Yael Laitman, Dana Madorsky Feldman, Miri Sklair-Levy, Ady Yosepovich, Iris Barshack-Nakar, Malka Brodsky, Osnat Halshtok, Anat Shalmon, Michael Gotlieb, Eitan Friedman. Clin Breast Cancer 2018
2

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Suzan Vreemann, Jan C M van Zelst, Margrethe Schlooz-Vries, Peter Bult, Nicoline Hoogerbrugge, Nico Karssemeijer, Albert Gubern-Mérida, Ritse M Mann. Breast Cancer Res 2018
18


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy